Mri Treatment Planning
Mri Treatment Planning - Related Videos
08:20
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
0 Views •
Cited by 31 •
2015
Here we outline the procedure for MRI-guided repetitive transcranial magnetic stimulation to the dorsomedial prefrontal cortex as an experimental treatment for major depressive disorder.
08:25
Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System
0 Views •
Cited by 60 •
2018
Radiation therapy is a highly complex cancer treatment that requires multiple specialists to create a treatment plan and provide quality assurance (QA) prior to delivery to a patient. This protocol describes the use of a fully automated system, the Radiation Planning Assistant (RPA), to create high-quality radiation treatment plans.
08:41
A MRI-Based Toolbox for Neurosurgical Planning in Nonhuman Primates
0 Views •
Cited by 9 •
2020
The method outlined below aims to provide a comprehensive protocol for the preparation of nonhuman primate (NHP) neurosurgery using a novel combination of three-dimensional (3D) printing methods and MRI data extraction.
07:11
Treatment of Facial Deformities using 3D Planning and Printing of Patient-Specific Implants
0 Views •
Cited by 9 •
2020
As technology develops and becomes more user-friendly, planning of operations and patient-specific surgical guides and fixation plates should be performed by the surgeon. We present a protocol for 3D planning of orthognathic skeletal movements and 3D planning and printing of patient-specific fixation plates and surgical guides.
06:06
Optogenetic Functional MRI
0 Views •
Cited by 15 •
2016
This protocol describes the steps and data analysis required to successfully perform optogenetic functional magnetic resonance imaging (ofMRI). ofMRI is a novel technique that combines high-field fMRI readout with optogenetic stimulation, allowing for cell type-specific mapping of functional neural circuits and their dynamics across the whole living brain.
FAQs
MRI findings are aligned with treatment-planning data so the visible tumor and surrounding anatomy correspond to the geometry used to design therapy. This alignment allows researchers and clinicians to use soft-tissue detail when defining treatment targets and nearby organs at risk. Its value depends on preserving a consistent relationship between the imaged anatomy and the planned treatment arrangement.
Detailed soft-tissue visualization can make tumor boundaries and neighboring structures easier to distinguish when they are difficult to separate with other imaging methods. That distinction supports more deliberate target delineation and identification of organs at risk. In turn, treatment planning can account for both the intended tumor region and sensitive anatomy surrounding it.
Repeated MRI assessment can show how anatomy and tumor characteristics change over time. Those observations provide research and planning context for judging whether the original target description and treatment geometry still represent the patient’s current condition. Tracking such changes supports investigation of more individualized strategies rather than treating the anatomy as permanently unchanged.
By clarifying the tumor region and nearby organs at risk, MRI-based planning supplies anatomical information for balancing treatment coverage against exposure to sensitive structures. The resulting geometry can be evaluated as part of dose optimization, with the aim of directing therapy toward the intended target while accounting for surrounding anatomy. This makes imaging information directly relevant to planning decisions.
A basic workflow uses MRI to characterize the tumor and surrounding anatomy, aligns those images with treatment-planning information, delineates the target and organs at risk, and establishes treatment geometry. The planning team can then use the mapped anatomy to optimize dose distribution and support image-guided treatment. Each step connects anatomical interpretation with the intended therapy design.
It is particularly useful when research requires detailed visualization of soft tissues, assessment of tumor boundaries, or observation of anatomical changes over time. Investigators can examine how tumor characteristics and surrounding structures relate to treatment design, while radiotherapy studies can assess target delineation, dose optimization, and image-guided approaches within a more individualized planning framework.
The planning process can provide mapped information about tumor extent, surrounding anatomy, organs at risk, and changes observed across time. These data help researchers study how anatomical or tumor characteristics influence treatment planning and how imaging can support individualized strategies. The information therefore serves both immediate planning needs and broader investigations of cancer therapy.